Drug-induced dilutional hyponatremia.
D000082:Acetaminophen / Q000009:adverse effects; D000639:Amitriptyline / Q000009:adverse effects; D000818:Animals; D001001:Anura; D001826:Body Fluids / Q000378:metabolism*; D002220:Carbamazepine / Q000009:adverse effects; D002747:Chlorpropamide / Q000627:therapeutic use; D002994:Clofibrate / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D003919:Diabetes Insipidus / Q000188:drug therapy / Q000503:physiopathology; D003920:Diabetes Mellitus / Q000188:drug therapy; D003981:Diazoxide / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007010:Hyponatremia / Q000139:chemically induced* / Q000378:metabolism; D007668:Kidney / Q000502:physiology; D051381:Rats; D012964:Sodium / Q000378:metabolism; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use; D014044:Tolbutamide / Q000009:adverse effects / Q000627:therapeutic use; D001743:Urinary Bladder / Q000502:physiology; D014667:Vasopressins / Q000378:metabolism / Q000502:physiology; D014750:Vincristine / Q000009:adverse effects; D014869:Water Intoxication / Q000378:metabolism; D014882:Water-Electrolyte Balance
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D014667:Vasopressins; D000639:Amitriptyline; D002220:Carbamazepine; D000082:Acetaminophen; D014750:Vincristine; D003520:Cyclophosphamide; D014044:Tolbutamide; D012964:Sodium; D002994:Clofibrate; D003981:Diazoxide; D002747:Chlorpropamide